Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Evelo Biosciences Inc EVLO

Healthcare Biotechnology
Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. It has built a platform to discover and develop oral medicines, which target the small intestinal axis (SINTAX). Its product candidates are pharmaceutical preparations of single... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:EVLO)

Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis

GlobeNewswire October 17, 2023

Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights

GlobeNewswire August 14, 2023

Evelo Biosciences Closes $25.5 Million Private Placement

GlobeNewswire July 12, 2023

Evelo Biosciences Announces $25.5 Million Private Placement

GlobeNewswire July 10, 2023

Evelo Biosciences Announces Reverse Stock Split Effective

GlobeNewswire June 29, 2023

Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry

PR Newswire May 16, 2023

Evelo Biosciences Provides Clinical Updates

GlobeNewswire April 26, 2023

Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights

GlobeNewswire March 16, 2023

Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

GlobeNewswire March 9, 2023
View More News ››

Opinion & Analysis (GREY:EVLO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (GREY:EVLO)

EVLO....Recent RS and more recent P.O at ~ $2.30

Give your head a shake The Powers to be give all the Shholders ahaircut...paper themselves up with the cheap P.O Bagholders need only...
Iseneschal - July 18, 2023
View more Bullboard ››

Sandstorm Gold Ltd.

Sandstorm Gold Ltd.

Sandstorm Gold Ltd. is a Canada-based precious metals-focused streaming and royalty company. The Company is focused on ...
View More »